STAVUDINE

Substance profile for UNII BO9LE4QFZF, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for STAVUDINE
Structure render from PubChem CID 18283

Substance Identity#

UNII
BO9LE4QFZF
Preferred term
STAVUDINE
Registry number
3056-17-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C10H12N2O4
Chemical structure for STAVUDINE
Structure render from PubChem CID 18283

Chemical And Database Identifiers#

InChIKey
XNKLLVCARDGLGL-JGVFFNPUSA-N
SMILES
CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O
RxCUI
59763
PubChem
18283
NCIt
C1428
INN ID
6775

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
STAVUDINEACTIVE MOIETYBO9LE4QFZFThese highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 19941
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFThese highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 19941
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution3
stavudineACTIVE MOIETYBO9LE4QFZFZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution3
STAVUDINEACTIVE INGREDIENTBO9LE4QFZF081991e0-eee4-4fa3-ac3d-0c32cb03e7f31
STAVUDINEACTIVE MOIETYBO9LE4QFZF081991e0-eee4-4fa3-ac3d-0c32cb03e7f31
STAVUDINEACTIVE MOIETYBO9LE4QFZF752d2c13-5ca5-40b3-b066-55a9b6b1287a1
STAVUDINEACTIVE INGREDIENTBO9LE4QFZF752d2c13-5ca5-40b3-b066-55a9b6b1287a1
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE (STAVUDINE) CAPSULE [REMEDYREPACK INC. ]80
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE (STAVUDINE) CAPSULE [REMEDYREPACK INC. ]80
stavudineACTIVE INGREDIENTBO9LE4QFZFZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.]23
stavudineACTIVE MOIETYBO9LE4QFZFZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.]23
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED]9
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED]9
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE CAPSULE [AUROBINDO PHARMA LIMITED]8
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE CAPSULE [AUROBINDO PHARMA LIMITED]8
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE CAPSULE [MYLAN PHARMACEUTICALS INC.]7
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE CAPSULE [MYLAN PHARMACEUTICALS INC.]7
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE FOR SOLUTION [CIPLA LIMITED]4
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE FOR SOLUTION [CIPLA LIMITED]4
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE CAPSULE [CAMBER PHARMACEUTICALS, INC.]2
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE CAPSULE [CAMBER PHARMACEUTICALS, INC.]2
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE SOLUTION [BOCA PHARMACAL, LLC]2
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE SOLUTION [BOCA PHARMACAL, LLC]2
STAVUDINEACTIVE MOIETYBO9LE4QFZFSTAVUDINE CAPSULE [KAISER FOUNDATION HOSPITALS]1
STAVUDINEACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE CAPSULE [KAISER FOUNDATION HOSPITALS]1
StavudineACTIVE INGREDIENTBO9LE4QFZFSTAVUDINE POWDER, FOR SOLUTION [EDENBRIDGE PHARMACEUTICALS, LLC]1
StavudineACTIVE MOIETYBO9LE4QFZFSTAVUDINE POWDER, FOR SOLUTION [EDENBRIDGE PHARMACEUTICALS, LLC]1